Gabelli Merger Plus+ Trust Plc
|Celgene Corp||6.32 %|
|BB&T Corp||4.84 %|
|SunTrust Banks Inc||4.81 %|
|Medidata Solutions Inc||4.51 %|
|Zayo Group Holdings Inc||4.47 %|
|Versum Materials Inc||4.38 %|
|Mellanox Technologies Ltd||4.22 %|
|Allergan PLC||3.77 %|
|WABCO Holdings Inc||3.65 %|
|Spark Therapeutics Inc||3.52 %|
|United States||95.72 %|
|Consumer Cyclical||16.81 %|
|Basic materials||8.21 %|
|Financial Services||5.82 %|
Gabelli is a managing director with Gabelli Funds, Inc., his employer since 1993. Previously, he was with Lehman Bothers for three years and with Balfour Maclaine.
Mario Gabelli is the Founder, Chairman and Chief Investment Officer. Mr. Gabelli is one of the most respected investors in the United States and is a leading proponent of value investing. His proprietary Private Market Value with a Catalyst™ methodology has become an analytical standard in the value investing community. He holds an MBA from Columbia University Graduate School of Business, and is a summa cum laude BS graduate from Fordham University. Mr. Gabelli is a Chartered Financial Analyst. He is a member of the board of overseers of Columbia University Graduate School of Business.
Robert D. Leininger, CFA, joined GBL in 1993 as a security analyst. Mr. Leininger moved to Rorer Asset Management LLC in Philadelphia in 1997, where he was a partner in the firm and member of the investment policy committee. In August 2009, he joined Copeland Capital Management as a partner and portfolio manager before rejoining GBL in 2010 where he currently serves as a portfolio manager for the Adviser and on GAMCO’s institutional and high net worth separate accounts team. He is a member of the Financial Analyst Society of Philadelphia. Mr. Leininger is a magna cum laude graduate of Amherst College with a degree in Economics and holds an MBA from the Wharton School at the University of Pennsylvania.
Data provided by Morningstar.
The Content is only for your general information and use and is not intended to address your particular requirements. The Content does not constitute any form of advice, recommendation or arrangement by Moneywise and is not intended to be relied upon by you in making (or refraining from making) any specific investment or other decisions. Appropriate independent advice should be obtained before making any such decision.
This information is sourced from our partner Morningstar. We believe the data to be correct however you should take care in using any information.
You should be aware that prices may fall as well as rise and that the income derived can go down as well as up. When buying or selling any investment that fluctuates in price or value you may get back less than you invested. Past performance is not necessarily a guide to future performance.